BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20434459)

  • 1. Dissecting the alternatively folded state of the antibody Fab fragment.
    Feige MJ; Simpson ER; Herold EM; Bepperling A; Heger K; Buchner J
    J Mol Biol; 2010 Jun; 399(5):719-30. PubMed ID: 20434459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The folding pathway of the antibody V(L) domain.
    Simpson ER; Herold EM; Buchner J
    J Mol Biol; 2009 Oct; 392(5):1326-38. PubMed ID: 19647749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.
    Röthlisberger D; Honegger A; Plückthun A
    J Mol Biol; 2005 Apr; 347(4):773-89. PubMed ID: 15769469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradomain disulfide bonds impede formation of the alternatively folded state of antibody chains.
    Buchner J; Rudolph R; Lilie H
    J Mol Biol; 2002 May; 318(3):829-36. PubMed ID: 12054826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
    Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
    J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of antibody chains at different stages of folding: prolyl isomerization occurs after formation of quaternary structure.
    Lilie H; Rudolph R; Buchner J
    J Mol Biol; 1995 Apr; 248(1):190-201. PubMed ID: 7731044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering antibodies for stability and efficient folding.
    Honegger A
    Handb Exp Pharmacol; 2008; (181):47-68. PubMed ID: 18071941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermal induction of an alternatively folded state in human IgG-Fc.
    Kanmert D; Brorsson AC; Jonsson BH; Enander K
    Biochemistry; 2011 Feb; 50(6):981-8. PubMed ID: 21261247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
    Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
    Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based stability engineering of the mouse IgG1 Fab fragment by modifying constant domains.
    Teerinen T; Valjakka J; Rouvinen J; Takkinen K
    J Mol Biol; 2006 Aug; 361(4):687-97. PubMed ID: 16876195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncovalent association of heavy and light chains of human immunoglobulins. IV. The roles of the CH1 and CL domains in idiotypic expression.
    Rinfret A; Horne C; Dorrington KJ; Klein M
    J Immunol; 1985 Oct; 135(4):2574-81. PubMed ID: 3928754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a quaternary-structured folding intermediate of an antibody Fab-fragment.
    Lilie H; Jaenicke R; Buchner J
    Protein Sci; 1995 May; 4(5):917-24. PubMed ID: 7663347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
    Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
    J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the domain-domain interaction in the construction of the antigen combining site. A comparative study by 1H-15N shift correlation NMR spectroscopy of the Fv and Fab fragments of anti-dansyl mouse monoclonal antibody.
    Takahashi H; Tamura H; Shimba N; Shimada I; Arata Y
    J Mol Biol; 1994 Oct; 243(3):494-503. PubMed ID: 7966275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Domain interactions stabilize the alternatively folded state of an antibody Fab fragment.
    Lilie H; Buchner J
    FEBS Lett; 1995 Mar; 362(1):43-6. PubMed ID: 7698350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refined structure of an intact IgG2a monoclonal antibody.
    Harris LJ; Larson SB; Hasel KW; McPherson A
    Biochemistry; 1997 Feb; 36(7):1581-97. PubMed ID: 9048542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody variable region binding by Staphylococcal protein A: thermodynamic analysis and location of the Fv binding site on E-domain.
    Starovasnik MA; O'Connell MP; Fairbrother WJ; Kelley RF
    Protein Sci; 1999 Jul; 8(7):1423-31. PubMed ID: 10422830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High level production of functional antibody Fab fragments in an oxidizing bacterial cytoplasm.
    Venturi M; Seifert C; Hunte C
    J Mol Biol; 2002 Jan; 315(1):1-8. PubMed ID: 11771962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alternatively folded state of the antibody C(H)3 domain.
    Thies MJ; Kammermeier R; Richter K; Buchner J
    J Mol Biol; 2001 Jun; 309(5):1077-85. PubMed ID: 11399080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular dynamics simulations highlight mobile regions in proteins: A novel suggestion for converting a murine V(H) domain into a more tractable species.
    Voordijk S; Hansson T; Hilvert D; van Gunsteren WF
    J Mol Biol; 2000 Jul; 300(4):963-73. PubMed ID: 10891281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.